Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

NCT05624450 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

2870

Enrollment

INDUSTRY

Sponsor class

Conditions

Viral Lung Infection and Acute Respiratory Failure

Interventions

DRUG: Tozorakimab
DRUG: Placebo

Sponsor

AstraZeneca